Galletta, F.; Rizzuti, L.; Passanisi, S.; Rosa, E.; Caminiti, L.; Manti, S.
Efficacy and Safety of Omalizumab and Dupilumab in Pediatric Patients with Skin Diseases: An Observational Study. J. Pers. Med. 2025, 15, 64.
https://doi.org/10.3390/jpm15020064
AMA Style
Galletta F, Rizzuti L, Passanisi S, Rosa E, Caminiti L, Manti S.
Efficacy and Safety of Omalizumab and Dupilumab in Pediatric Patients with Skin Diseases: An Observational Study. Journal of Personalized Medicine. 2025; 15(2):64.
https://doi.org/10.3390/jpm15020064
Chicago/Turabian Style
Galletta, Francesca, Ludovica Rizzuti, Stefano Passanisi, Emanuela Rosa, Lucia Caminiti, and Sara Manti.
2025. "Efficacy and Safety of Omalizumab and Dupilumab in Pediatric Patients with Skin Diseases: An Observational Study" Journal of Personalized Medicine 15, no. 2: 64.
https://doi.org/10.3390/jpm15020064
APA Style
Galletta, F., Rizzuti, L., Passanisi, S., Rosa, E., Caminiti, L., & Manti, S.
(2025). Efficacy and Safety of Omalizumab and Dupilumab in Pediatric Patients with Skin Diseases: An Observational Study. Journal of Personalized Medicine, 15(2), 64.
https://doi.org/10.3390/jpm15020064
